CP

Convert Pharmaceuticals

BE0671.828.631

Income Statement
Financial year
Operating income
Gross margin
€ 116,254
Turnover
Stock of work in progress and finished goods and contracts in progress: increase (decrease)
Fixed assets produced
Other operating income
Operating expenses
Trade goods, raw and auxiliary materials
Purchases
Stock: decrease (increase)
Services and miscellaneous goods
Remuneration, social security charges and pensions
€ 71,491
Depreciation and amortization of formation expenses, intangible and tangible assets
€ 566,355
Write-downs on inventories, contracts in progress and trade receivables: additions (reversals)
Provisions for liabilities and charges: additions (uses and reversals)
Other operating expenses
€ 796
Non-recurring operating expenses
Operating profit (Operating loss)
€ -522,389
Financial returns
€ 267,421
Recurring financial income
€ 267,421
Income from current assets
Other financial income
Non-recurring financial income
Financial costs
€ 25,789
Recurring financial costs
€ 25,789
Cost of debt
Write-downs on current assets other than inventories, contracts in progress and trade receivables: additions (reversals)
Other financial costs
Non-recurring financial charges
Profit (Loss) for the year before taxes
€ -280,757
Withdrawal from deferred taxes
Income taxes
€ -3,497
Taxes
Regularization of taxes and reversal of provisions for taxes
Profit (Loss) for the fiscal year
€ -277,261
Withdrawal from tax-exempt reserves
Profit (loss) for the year to be appropriated
€ -277,261
Results processing
Financial year
Profit (loss) to be appropriated
Profit (loss) for the year to be appropriated
€ -277,261
Profit (loss) carried forward from the previous fiscal year
€ -1,539,702
Addition to equity
Accumulated profits losses
€ -1,816,963
Profit to be distributed
Assets
Financial year
COSTS
FIXED ASSETS
€ 860,458
Intangible fixed assets
€ 860,458
Tangible fixed assets
Land buildings
Plant machinery equipment
FUrniture vehicles
Other tangible assets
Assets under construction and prepayments
Financial fixed assets
Affiliated financial fixed assets
Participations
Receivables
Other financial fixed assets
Shares and units
Receivables and cash guarantees
CURRENT ASSETS
€ 740,526
Non-current receivables
Other receivables
Inventories and orders in progress
Stocks
Merchandise
Orders in progress
Receivables due within one year
€ 92,883
Trade receivables
€ 86,636
Other receivables
€ 6,247
Money investments
Own shares
Other investments
Cash and cash equivalents
€ 647,643
Accrued expenses
ASSETS
€ 1,600,984
Liabilities
Financial year
EQUITY
€ -296,777
Equity contribution
€ 1,520,186
Unavailable
Capital
€ 1,270,186
Issues capital
€ 1,270,186
Outside capital
€ 250,000
Issue premiums
€ 250,000
Revaluation capital gains
Reserves
Unavailable reserves
Legal reserve
Purchase of own shares
Other reserves
Tax-free reserves
Available reserves
Accumulated profits losses
€ -1,816,963
Investment grants
PROVISIONS AND DEFERRED TAXES
Provisions for risks and costs
Pensions and similar obligations
Other risks and costs
Deferred taxes
Amounts payable
€ 1,897,761
Non-current liabilities
€ 1,702,595
Financial debts
€ 1,702,595
Unsubordinated debentures
Credit Institutions
Other loans
€ 1,702,595
Amounts payable within one year
€ 195,166
Financial debts
Credit Institutions
Other loans
Trade debts payables
€ 193,405
Suppliers
€ 193,405
Prepayments on orders
Liabilities related to taxes, remuneration and social security contributions
€ 1,760
Taxes
€ 1,760
Remuneration and social charges
Other liabilities
Accrued expenses
TOTAL LIABILITIES
€ 1,600,984
Social Balance Sheet
Financial year
Average number of employees
Total FTE
Total headcount
Full-time
Part-time
Fixed-term contracts (FTE)
FTE men
FTE women
Personnel costs
Hours worked men
Hours worked women
Temporary staff
Temporary staff costs